Atnaujinkite slapukų nuostatas

El. knyga: New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science

  • Formatas: 158 pages
  • Išleidimo metai: 07-Jul-2011
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309162982
  • Formatas: 158 pages
  • Išleidimo metai: 07-Jul-2011
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309162982

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of povertythe vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world.



Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.

Table of Contents



Front Matter 1 Introduction 2 A Global Perspective on Drug-Resistant Tuberculosis 3 Drug-Resistant Tuberculosis in the Russian Federation 4 Transmission and Infection Control of Drug-Resistant TB 5 Diagnosis of Drug-Resistant TB 6 Treatment of Drug-Resistant TB 7 TB and Drug-Resistant TB in Vulnerable Populations 8 The Second-Line Drug Supply Chain 9 The Development of New TB Diagnostics and Drugs 10 Convergence of Science and Policy to Create a Call for Action References Appendix A: Agenda Appendix B: Summary of a Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Held May 2425, 2010, Moscow, Russian Federation Appendix C: Participant Biographies
Acronyms xvii
1 Introduction
1(8)
The Problem of Drug Resistance
2(1)
The Burden of Drug-Resistant TB
2(2)
Workshop Objectives
4(2)
A Realistic Assessment of the Challenges of Drug-Resistant TB
6(1)
Organization of the Report
7(2)
2 A Global Perspective on Drug-Resistant Tuberculosis
9(20)
Difficulties in Estimating the Burden of MDR TB
10(4)
MDR and XDR TB in South Africa
14(1)
MDR and XDR TB in China
14(5)
Historical Perspective on MDR TB Control Efforts
19(3)
Remaining Challenges
22(7)
3 Drug-Resistant Tuberculosis in the Russian Federation
29(8)
A Historical Perspective
30(1)
Epidemiology of TB in the Russian Federation
31(3)
National MDR TB Surveillance System
34(3)
4 Transmission and Infection Control of Drug-Resistant TB
37(12)
Transmission of Drug-Resistant TB in China
38(1)
Transmission-Based Genetic Analysis in South Africa
39(3)
Reducing Nosocomial Drug-Resistant TB Transmission
42(7)
5 Diagnosis of Drug-Resistant TB
49(14)
Rapid Diagnostic Methods
50(4)
Biochip Technology for TB Diagnosis
54(1)
Need for Improved Laboratory Capacity
55(8)
6 Treatment of Drug-Resistant TB
63(12)
PETTS: Making the Case for Drug Resistance Testing and Tailored Treatment Regimens
64(3)
Treatment of Drug-Resistant TB in the Russian Federation
67(1)
Drug-Resistant TB and Coinfection with HIV
68(3)
Innovative Research in MDR TB Treatment
71(4)
7 TB and Drug-Resistant TB in Vulnerable Populations
75(12)
Drug-Resistant TB in Children: The Hidden Epidemic
76(4)
MDR TB Treatment for People with Drug and Alcohol Dependencies
80(4)
TB in the Prison System of the Russian Federation
84(3)
8 The Second-Line Drug Supply Chain
87(8)
A New Paradigm for the Drug Supply for Drug-Resistant TB
88(2)
MDR TB Treatment and the Drug Supply Chain in the Russian Federation
90(5)
9 The Development of New TB Diagnostics and Drugs
95(6)
The Global Challenge
96(1)
The Role of Regulatory Science
97(2)
The Need for Collaboration
99(2)
10 Convergence of Science and Policy to Create a Call for Action
101(8)
Key Challenges
101(2)
Infection Control
103(1)
Diagnostics
103(1)
Treatment
103(1)
High-Quality Care for All
104(2)
Linkages from Science to Clinical Care
106(3)
References
109
A Agenda
113(8)
B Summary of a Meeting of The National Institute of Allergy and Infectious Diseases, National Institutes of health, held may 24--25, 2010, Moscow, Russian Federation
121(2)
C Participant Biographies
123